{"entity":{"type":"insider","cik":"0001364719","url":"/insider/0001364719","json_url":"/insider/0001364719.json","name":"Kauffman Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":87,"n_filings":60,"first":"2014-06-19","last":"2025-11-25","span_basis":"filed_date"},"name_variants":[{"name":"Kauffman Michael","source":"filing","n_filings":60,"first_seen":"2014-06-19","last_seen":"2025-11-25"}],"transactions":[{"id":4030158,"accession":"0001104659-25-116060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-116060","line_url":"/filing/0001104659-25-116060#line-1","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Verastem, Inc.","issuer_ticker":"VSTM","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8550.0,"shares_display":"8,550","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":85500.0,"total_display":"85,500.00","total_whole":"85,500","shares_owned_after":8666.0,"shares_owned_after_display":"8,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-25","scope":"insider"},{"id":3074284,"accession":"0000950170-24-070605","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-070605","line_url":"/filing/0000950170-24-070605#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5900.0,"shares_display":"5,900","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":8437.0,"total_display":"8,437.00","total_whole":"8,437","shares_owned_after":5900.0,"shares_owned_after_display":"5,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-07","scope":"insider"},{"id":6345294,"accession":"0001209191-22-014624","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-014624","line_url":"/filing/0001209191-22-014624","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12452.0,"shares_display":"12,452","price_per_share":10.2375,"price_display":"10.24","price_state":"stated","total_value":127477.35,"total_display":"127,477.35","total_whole":"127,477","shares_owned_after":898131.0,"shares_owned_after_display":"898,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider","n_lines":2},{"id":6947422,"accession":"0001209191-22-011636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-011636","line_url":"/filing/0001209191-22-011636","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18167.0,"shares_display":"18,167","price_per_share":12.1234,"price_display":"12.12","price_state":"stated","total_value":220245.8078,"total_display":"220,245.81","total_whole":"220,246","shares_owned_after":904357.0,"shares_owned_after_display":"904,357","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider","n_lines":2},{"id":6120211,"accession":"0001209191-22-008124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008124","line_url":"/filing/0001209191-22-008124","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13471.0,"shares_display":"13,471","price_per_share":9.862,"price_display":"9.86","price_state":"stated","total_value":132851.002,"total_display":"132,851.00","total_whole":"132,851","shares_owned_after":708062.0,"shares_owned_after_display":"708,062","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":2},{"id":6446473,"accession":"0001209191-22-001964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-001964","line_url":"/filing/0001209191-22-001964#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.45,"price_display":"16.45","price_state":"stated","total_value":82250.0,"total_display":"82,250.00","total_whole":"82,250","shares_owned_after":63690.0,"shares_owned_after_display":"63,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":4092086,"accession":"0001209191-21-022486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-022486","line_url":"/filing/0001209191-21-022486#line-1","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":12.3882,"price_display":"12.39","price_state":"stated","total_value":49552.8,"total_display":"49,552.80","total_whole":"49,553","shares_owned_after":714826.0,"shares_owned_after_display":"714,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-18","filed_date":"2021-03-23","scope":"insider"},{"id":5191019,"accession":"0001209191-21-012960","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012960","line_url":"/filing/0001209191-21-012960","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18990.0,"shares_display":"18,990","price_per_share":14.8312,"price_display":"14.83","price_state":"stated","total_value":281644.488,"total_display":"281,644.49","total_whole":"281,644","shares_owned_after":776452.0,"shares_owned_after_display":"776,452","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-22","scope":"insider","n_lines":2},{"id":5520109,"accession":"0001209191-21-011484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-011484","line_url":"/filing/0001209191-21-011484","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13243.0,"shares_display":"13,243","price_per_share":15.519,"price_display":"15.52","price_state":"stated","total_value":205518.117,"total_display":"205,518.12","total_whole":"205,518","shares_owned_after":764147.0,"shares_owned_after_display":"764,147","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-17","scope":"insider","n_lines":2},{"id":3260837,"accession":"0001209191-20-054822","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-054822","line_url":"/filing/0001209191-20-054822#line-3","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":14.891,"price_display":"14.89","price_state":"stated","total_value":111682.5,"total_display":"111,682.50","total_whole":"111,683","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-12","filed_date":"2020-10-14","scope":"insider"},{"id":2833292,"accession":"0001209191-20-047279","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047279","line_url":"/filing/0001209191-20-047279#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1477.0,"shares_display":"1,477","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":22155.0,"total_display":"22,155.00","total_whole":"22,155","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":2832904,"accession":"0001209191-20-042845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042845","line_url":"/filing/0001209191-20-042845#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.4297,"price_display":"19.43","price_state":"stated","total_value":145722.75,"total_display":"145,722.75","total_whole":"145,723","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-17","scope":"insider"},{"id":2586381,"accession":"0001209191-20-042310","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-042310","line_url":"/filing/0001209191-20-042310","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.005228,"price_display":"19.01","price_state":"stated","total_value":142539.21,"total_display":"142,539.21","total_whole":"142,539","shares_owned_after":555422.0,"shares_owned_after_display":"555,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-10","filed_date":"2020-07-13","scope":"insider","n_lines":2},{"id":2586368,"accession":"0001209191-20-042310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-042310","line_url":"/filing/0001209191-20-042310#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":19.5316,"price_display":"19.53","price_state":"stated","total_value":146487.0,"total_display":"146,487.00","total_whole":"146,487","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-09","filed_date":"2020-07-13","scope":"insider"},{"id":2287444,"accession":"0001209191-20-038718","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038718","line_url":"/filing/0001209191-20-038718#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-24","scope":"insider"},{"id":2544875,"accession":"0001209191-20-037229","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-037229","line_url":"/filing/0001209191-20-037229","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":16.37057484,"price_display":"16.37","price_state":"stated","total_value":122779.3113,"total_display":"122,779.31","total_whole":"122,779","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-17","scope":"insider","n_lines":2},{"id":2338115,"accession":"0001209191-20-035949","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-035949","line_url":"/filing/0001209191-20-035949#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.1259,"price_display":"18.13","price_state":"stated","total_value":135944.25,"total_display":"135,944.25","total_whole":"135,944","shares_owned_after":555122.0,"shares_owned_after_display":"555,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-11","scope":"insider"},{"id":2338109,"accession":"0001209191-20-035949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-035949","line_url":"/filing/0001209191-20-035949#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.4994,"price_display":"18.50","price_state":"stated","total_value":138745.5,"total_display":"138,745.50","total_whole":"138,746","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-11","scope":"insider"},{"id":2782448,"accession":"0001209191-20-030615","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-030615","line_url":"/filing/0001209191-20-030615#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-19","scope":"insider"},{"id":2782433,"accession":"0001209191-20-030615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-030615","line_url":"/filing/0001209191-20-030615#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":18.6454,"price_display":"18.65","price_state":"stated","total_value":139840.5,"total_display":"139,840.50","total_whole":"139,841","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider"},{"id":2369413,"accession":"0001209191-20-028261","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-028261","line_url":"/filing/0001209191-20-028261","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":19.6276,"price_display":"19.63","price_state":"stated","total_value":294414.0,"total_display":"294,414.00","total_whole":"294,414","shares_owned_after":555122.0,"shares_owned_after_display":"555,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider","n_lines":2},{"id":2831462,"accession":"0001209191-20-024148","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-024148","line_url":"/filing/0001209191-20-024148#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.6404,"price_display":"20.64","price_state":"stated","total_value":206404.0,"total_display":"206,404.00","total_whole":"206,404","shares_owned_after":555122.0,"shares_owned_after_display":"555,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-10","scope":"insider"},{"id":2831455,"accession":"0001209191-20-024148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-024148","line_url":"/filing/0001209191-20-024148#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.6115,"price_display":"18.61","price_state":"stated","total_value":186115.0,"total_display":"186,115.00","total_whole":"186,115","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":3311646,"accession":"0001209191-20-018258","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-018258","line_url":"/filing/0001209191-20-018258","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.21859692,"price_display":"22.22","price_state":"stated","total_value":222185.9692,"total_display":"222,185.97","total_whole":"222,186","shares_owned_after":557190.0,"shares_owned_after_display":"557,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-11","scope":"insider","n_lines":2},{"id":3311634,"accession":"0001209191-20-018258","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-018258","line_url":"/filing/0001209191-20-018258","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.51946,"price_display":"22.52","price_state":"stated","total_value":225194.6,"total_display":"225,194.60","total_whole":"225,195","shares_owned_after":759489.0,"shares_owned_after_display":"759,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider","n_lines":2},{"id":2542168,"accession":"0001209191-20-011687","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-011687","line_url":"/filing/0001209191-20-011687","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17634.0,"shares_display":"17,634","price_per_share":16.4819,"price_display":"16.48","price_state":"stated","total_value":290641.8246,"total_display":"290,641.82","total_whole":"290,642","shares_owned_after":756489.0,"shares_owned_after_display":"756,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider","n_lines":2},{"id":2779504,"accession":"0001209191-20-008727","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-008727","line_url":"/filing/0001209191-20-008727#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.4294,"price_display":"17.43","price_state":"stated","total_value":174294.0,"total_display":"174,294.00","total_whole":"174,294","shares_owned_after":542139.0,"shares_owned_after_display":"542,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":2779491,"accession":"0001209191-20-008727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008727","line_url":"/filing/0001209191-20-008727#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.9327,"price_display":"16.93","price_state":"stated","total_value":169327.0,"total_display":"169,327.00","total_whole":"169,327","shares_owned_after":743506.0,"shares_owned_after_display":"743,506","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":2432872,"accession":"0001209191-20-003088","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-003088","line_url":"/filing/0001209191-20-003088#line-6","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.188,"price_display":"19.19","price_state":"stated","total_value":191880.0,"total_display":"191,880.00","total_whole":"191,880","shares_owned_after":542139.0,"shares_owned_after_display":"542,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-10","scope":"insider"},{"id":2432865,"accession":"0001209191-20-003088","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-003088","line_url":"/filing/0001209191-20-003088#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.5705,"price_display":"18.57","price_state":"stated","total_value":185705.0,"total_display":"185,705.00","total_whole":"185,705","shares_owned_after":743506.0,"shares_owned_after_display":"743,506","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":8069927,"accession":"0001209191-19-060074","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-060074","line_url":"/filing/0001209191-19-060074#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.9896,"price_display":"15.99","price_state":"stated","total_value":159896.0,"total_display":"159,896.00","total_whole":"159,896","shares_owned_after":529767.0,"shares_owned_after_display":"529,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider"},{"id":8069919,"accession":"0001209191-19-060074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060074","line_url":"/filing/0001209191-19-060074#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.021,"price_display":"17.02","price_state":"stated","total_value":170210.0,"total_display":"170,210.00","total_whole":"170,210","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7842504,"accession":"0001209191-19-056041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-056041","line_url":"/filing/0001209191-19-056041#line-4","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.761,"price_display":"14.76","price_state":"stated","total_value":147610.0,"total_display":"147,610.00","total_whole":"147,610","shares_owned_after":529767.0,"shares_owned_after_display":"529,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-12","scope":"insider"},{"id":7842498,"accession":"0001209191-19-056041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056041","line_url":"/filing/0001209191-19-056041#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.6254,"price_display":"14.63","price_state":"stated","total_value":146254.0,"total_display":"146,254.00","total_whole":"146,254","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-12","scope":"insider"},{"id":8241054,"accession":"0001209191-19-055167","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-055167","line_url":"/filing/0001209191-19-055167","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-05","scope":"insider","n_lines":2},{"id":8568885,"accession":"0001209191-19-049870","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049870","line_url":"/filing/0001209191-19-049870","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-17","scope":"insider","n_lines":2},{"id":8188936,"accession":"0001209191-19-003066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003066","line_url":"/filing/0001209191-19-003066#line-2","is_derivative":false,"issuer_cik":"0001364719","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001364719","owner_cik":"0001364719","owner_name":"Kauffman Michael","owner_display_name":"Kauffman Michael","owner_url":"/insider/0001364719","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":10.2259,"price_display":"10.23","price_state":"stated","total_value":127823.75,"total_display":"127,823.75","total_whole":"127,824","shares_owned_after":731134.0,"shares_owned_after_display":"731,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-09","scope":"insider"}],"collapsed":true,"next_cursor":"2019-01-07|8188936","ledger_fault":false,"count":{"value":87,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":85,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":87},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001526119","name":"Verastem, Inc.","url":"/issuer/0001526119","role":"Director","n_filings":4,"first_seen":"2014-09-18","last_seen":"2025-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director","n_filings":1,"first_seen":"2024-06-07","last_seen":"2024-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Director, Officer (Chief Executive Officer)","n_filings":54,"first_seen":"2014-06-19","last_seen":"2022-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Director","n_filings":1,"first_seen":"2022-01-05","last_seen":"2022-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001364719","retrieved_at":"2026-08-27T04:08:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}